Bachem AG

CATALOG PEPTIDES

Our innovative peptides portfolio includes a variety of sequence modifications, and salt forms, as well as established bioactive peptides used in different applications such as Alzheimer’s, diabetes and cancer research.

Bachem’s collection of amino acid derivatives and special building blocks is a key resource when synthesizing high quality and structurally complex peptides.

For more details, read through our product catalog.

WHAT BACHEM OFFERS

Bachem is continuously expanding and updating its extensive range of biologically active peptides in different applications such as:

• Alzheimer’s Disease
• Antimicrobial & Antiviral Peptides
• Amyloid Peptides
• Cancer Research
• Cardiovascular System & Diseases
• Cosmetics Peptides
• Diabetes
• Food research & Nutrition
• Gastrointestinal Research
• Infectious Disease
• Multiple Sclerosis
• Obesity Research
• Opioid Research
• Osteoporosis Research
• Parkinson’s Disease
• Veterinairy

WHY CHOOSE BACHEM?

• Customer centricity & service – We offer the highest quality products and services in the industry and we stand for trusting and long-standing partnerships. Our customers appreciate our broad knowledge, experience, and expertise in the entire field of development and production of peptides.
• Innovation and technology – We are passionate about innovation with a strong focus on realizing value in all areas of the company.
• Operational excellence and quality – The pharmaceutical and biotechnology business requires the most stringent manufacturing standards in the world and demands absolute perfection in quality.
• People & culture – Our employees make the difference. We are enthusiastic about technology and constant innovation and at the same time proud of our reliability and our solution oriented, hands-on mentality.
• Sustainability – We are convinced that ethically correct behavior and integrity are essential for long-term business success and therefore continuously monitor and improve our social, economic and environmental performance.